by Livio Andrea Acerbo November 26, 2025July 20, 2026 There may not be a safe off-ramp for some taking GLP-1 drugs, study suggests Uncategorized In trial, 82% saw weight rebound and cardiovascular health reverse after withdrawal. Post navigation « Trump’s Peace Plan for Ukraine Sparks Debate Amid Russia’s Ongoing Assault on Kyiv – 11/26/2025, 8:29:28 AMCampbell’s promises its soups are not made with 3D printed meat » Privacy · Cookies · Terms We use essential cookies and, only with your consent, analytics cookies. Read our Cookie Policy. Reject Accept
In trial, 82% saw weight rebound and cardiovascular health reverse after withdrawal.
In trial, 82% saw weight rebound and cardiovascular health reverse after withdrawal.